MyICID concerned about Ivermectin as Covid treatment

by SHAFIQQUL ALIFF / pic by AFP 

MALAYSIA Society of Infection Control and Infectious Diseases (MyICID) is worried about people using Ivermectin as prevention and treatment for Covid-19 before its approval for these uses.

Ivermectin is an anti-parasitic drug with good efficacy and safety profile.

MyICID said Ivermectin’s potential for Covid-19 prevention and treatment is based on laboratory evidence, anecdotal reports and several early clinical trials.

However, results from well-designed, large randomised controlled trials are needed to determine the efficacy and safety of Ivermectin for Covid-19 treatment.

“To date, there are more than 80 randomised controlled trials on Ivermectin which are either completed or ongoing around the world.

“A large-scale trial like the PRINCIPLE study by the Oxford scientist should provide an answer if this drug can be repurposed as an antiviral to treat Covid-19. Locally, Malaysia is conducting a similar clinical trial involving 500 high-risk Covid-19 subjects,” MyICID said in a statement.

MyICID said the results from these trials will yield scientific evidence, not only on the role of Ivermectin in Covid-19 treatment, but also on the optimal dose and duration needed for effective outcomes without adverse effects to patients.

Currently, well-recognised health organisations and authorities such as the World Health Organisation, US Food and Drug Administration, Infectious Disease Society of America, European Medicines Agency, as well as Malaysia’s Ministry of Health (MoH) have recommended the use of Ivermectin only in the setting of clinical trials, which my MyICID agrees on.

MyICID said there were reports that people are buying and consuming the drug meant for animal use and getting ill.

“As consumers, we must exercise our rights and wisdom to understand the risk and benefit of any medication before taking them.

“We strongly urge the Malaysian public to heed the advice and adhere to the current treatment recommendations by MoH and other international health agencies which are rigorously evaluating the efficacy and safety of Ivermectin in Covid-19 treatment,” MyICID stated in a statement.